T. P. Hughes, J. Kaeda, S. Branford, et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytara- bine in newly diagnosed chronic myeloid leukemia. The New England Journal of Medicine, 2003, 349(15): 1421-1432.

伊马替尼和尼洛替尼治疗慢性粒细胞白血病的疗效比较研究
Observation of Imatinib and Nilotinib in the Treatment of Chronic Myeloid Leukemia

王宇瑶, 杨 洁, 李 杰, 王瑞仓, 袁 军, 李 燕, 张晓霞, 郝洪岭   

世界肿瘤研究Vol.9 No.2, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2019.92010, April 9 2019

慢性髓细胞白血病对伊马替尼产生耐药性的机制
Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

夏君燕, 朱 平   

世界肿瘤研究Vol.2 No.3, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2012.23003, July 26 2012

干扰素-α联合达沙替尼治疗慢性粒细胞白血病取得深部分子反应1例并文献复习
Deep Molecular Response by IFN-α and Dasatinib Combination with Chronic Myeloid Leukemia: Report of One Case and Review of Literature

乔 晗, 冯献启   

临床医学进展Vol.11 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.115316, May 21 2021

达沙替尼治疗儿童慢性粒细胞白血病的进展分析
Analysis of the Progress of Dasatinib in the Treatment of Chronic Myeloid Leukemia in Children

覃 欢, 于 洁   

临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112918, December 31 2021

博舒替尼治疗慢性粒细胞白血病现状
Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia

余艳玲, 余 涛, 余 甜, 万茜茜   

临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131014, January 6 2023

表观遗传学治疗在急性髓系白血病中的研究进展
Research Progress of Epigenetic Therapy in Acute Myeloid Leukemia

杨香会, 付 滕, 张海亚, 王彦丽, 李 丽, 接贵涛   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281152, August 29 2022